Christoph Rudiger Antz
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$1K
Total bought / sold$8K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 31SEC | VRXAVeraxa Biotech AG - Post de-SPAC | Buy | 5,000new position | $1.53 | $8K | -17.6% |
- Buy
CEO Christoph Rudiger Antz bought $8K of VRXA at $1.53 — first open-market purchase in our records; opens a new position.